On March 11, it was revealed in an SEC filing that William E. Berry, Jr., VP at Stryker (NYSE:SYK) executed a significant exercise of company stock options.
What Happened: A Form 4 filing with the U.S. Securities and Exchange Commission on Monday revealed that Jr., VP at Stryker in the Health Care sector, exercised stock options for 19,140 shares of SYK stock. The exercise price of the options was $111.85 per share.
The Tuesday morning update indicates Stryker shares down by 1.4%, currently priced at $350.61. At this value, Jr.'s 19,140 shares are worth $4,569,975.
Delving into Stryker's Background
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
A Deep Dive into Stryker's Financials
Positive Revenue Trend: Examining Stryker's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of ...